Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immune Response of Liquid CAIV-T Influenza Vaccine in Healthy Adults
NCT00192231Phase 3Completed
- Sponsor
- MedImmune
- Start
- Apr 2001
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in influenza comparing CAIV-T with Placebo (2 arms). Primary endpoint: Safety and Tolerability of CAIV-T Vaccine. Started Apr 2001; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00192231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00192231.